Priv.Doz. Dr.
Lukas Weiss, PhD
Email:lu.weiss@salk.at
Onkologische Ambulanz + Ärztliche Leitung Tumorregister
1. Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia.
Weiss L, Melchardt T, Egle A, Grabmer C, Greil R, Tinhofer I.
Cancer. 2011 May 15;117(10):2163-9. doi: 10.1002/cncr.25752. Epub 2010 Nov 18
2. Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.
Gassner FJ, Weiss L, Geisberger R, Hofbauer JP, Egle A, Hartmann TN, Greil R, Tinhofer I.
Cancer Immunol Immunother. 2011 Jan;60(1):75-85. Epub 2010 Sep 21.
3. Complete Remission of Waldenstrom Macroglobulinemia With Azacitidine and Rituximab.
Weiss L, Melchardt T, Neureiter D, Kemmerling R, Pleyer L, Greil R, Egle A, Moshir S.
J Clin Oncol. 2011 Jul 5. [Epub ahead of print]
4. An uncommon cause of anaemia: Sheehan's syndrome.
Melchardt T, Namberger K, Weiss L, Egle A, Faber V, Greil R.
Wiener Klinische Wochenschrift. 2010 Dec 7.
5. Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
Tinhofer I, Weiss L, Gassner F, Rubenzer G, Holler C, Greil R.
Journal of Immunotherapy. 2009 Apr;32(3):302-9.
